Sorafenib tosylate is a salt form of sorafenib, a kinase inhibitor compound used as an active pharmaceutical ingredient in the manufacture of certain anticancer medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 475207-59-1
Sorafenib
Multikinase inhibitor for cancer research
Regorafenib
pharmaceutical raw material
Regorafenib monohydrate
pharmaceutical raw material
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
pharmaceutical intermediate
Adw-742
pharmaceutical raw material
GSK 621659A
pharmaceutical raw material
NVP-AEW541
pharmaceutical raw material
Isotretinoin
pharmaceutical raw material
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
IVDHYUQIDRJSTI-UHFFFAOYSA-N
CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F